Millennium Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
|
|||||
|
2025
Q1 | $41.3M | Sell |
|
|||||
|
2024
Q4 | $49.3M | Sell |
|
|||||
|
2024
Q3 | $74.9M | Buy |
|
|||||
|
2024
Q2 | $64.6M | Buy |
|
|||||
|
2024
Q1 | $54.7M | Buy |
|
|||||
|
2023
Q4 | $2.82M | Sell |
|
|||||
|
2023
Q3 | $4.01M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $919K | Sell |
|
|||||
|
2022
Q3 | $2.74M | Sell |
|
|||||
|
2022
Q2 | $6.04M | Sell |
|
|||||
|
2022
Q1 | $18.4M | Buy |
|
|||||
|
2021
Q4 | $16.9M | Sell |
|
|||||
|
2021
Q3 | $29.4M | Buy |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $8.89M | Sell |
|
|||||
|
2020
Q4 | $14.3M | Sell |
|
|||||
|
2020
Q3 | $18.7K | Sell |
|
|||||
|
2020
Q2 | $30.7M | Sell |
|
|||||
|
2020
Q1 | $30.4M | Sell |
|
|||||
|
2019
Q4 | $68M | Sell |
|
|||||
|
2019
Q3 | $97.3M | Sell |
|
|||||
|
2019
Q2 | $129M | Sell |
|
|||||
|
2019
Q1 | $162M | Buy |
|
|||||
|
2018
Q4 | $11.5M | Sell |
|
|||||
|
2018
Q3 | $15.3M | Sell |
|
|||||
|
2018
Q2 | $37.7M | Sell |
|
|||||
|
2018
Q1 | $43.5M | Buy |
|
|||||
|
2017
Q4 | $21.3M | Buy |
|
|||||
|
2017
Q3 | $18.6M | Buy |
|
|||||
|
2017
Q2 | $6.08M | Buy |
|
|||||
|
2017
Q1 | $3.88M | Sell |
|
|||||
|
2016
Q4 | $4.59M | Buy |
|
|||||
|
2016
Q3 | $1.53M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $378K | Sell |
|
|||||
|
2015
Q1 | $922K | Buy |
|